Clinical trials on COPD

  • CT-EU-00111332

    Improving COPD Management After Hospital Discharge: A Study on Rescue Packs

    If you or someone you know is living with Chronic Obstructive Pulmonary Disease (COPD), you might be familiar with the challenges it brings, especially the risk of exacerbations or episodes that worsen the condition. These episodes are significant because they can lead to hospital admissions and, unfortunately, have a high chance of happening again within 90 days after being discharged from the hospital. Recognizing this, a new study aims to explore whether providing supported rescue packs after discharge can help reduce the likelihood of being readmitted to the hospital.

    The study, titled “Supported Rescue Packs Post-discharge in Chronic Obstructive Pulmonary Disease: An Open-label Multicenter Randomised Controlled Trial,” will involve 1400 patients across 30 acute NHS trusts. It’s designed to test if a special management plan that includes rescue packs (a course of prednisolone and antibiotics), a written self-management plan, and twice-weekly telephone or text symptom alert assessments can be more effective than the usual care. The goal is to see if this approach can reduce readmissions by 20% within the critical 90-day period after hospital discharge.

    This research is not just about improving patient outcomes; it’s also about potentially saving the NHS approximately £350 million per year. By participating, you could be part of a significant effort to improve care for people with COPD and help reduce the strain on hospital resources, especially during the challenging winter months.

    The main thing the study will look at is the time to first all-cause readmission within 90 days of discharge. This means researchers will monitor how long it takes before someone might need to be readmitted to the hospital for any reason after being discharged.

    Participating in this study could offer a new way to manage COPD after a hospital stay, focusing on early intervention and support. It’s an opportunity to be part of groundbreaking research that could change how COPD exacerbations are managed post-discharge, potentially making a significant difference in the lives of those affected by this chronic condition.